NX-278-L

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNX-278-L
Drug Alias NameSELEX (NeXstar)VEGF antagonists (NeXstar)vascular endothelial growth factor antagonists (NeXstar)oligonucleotide (NeXstar)NX-278-L
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsAngiogenesis disorderMacular DegenerationSarcoma, Kaposi
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncEyetech Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderMacular DegenerationSarcoma, Kaposi

Other Information

ATC CodeN/A
Related LinksN/A